FDA Inspection 1196232 — Reproductive Medicine Associates Of Philadelphia, P.c.

Reproductive Medicine Associates Of Philadelphia, P.c. — FEI 3007936041

The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia, P.c. on January 24, 2023 in Langhorne, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Langhorne, PA (United States)